Grants and Contributions
About this information
In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.
The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.
Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.
$172,500.00
Jan 1, 2012
The use of Next Generation Exome sequencing in the identification of genes responsible for rare childhood neurologic disorders
$391,560.00
Dec 1, 2011
The Role of Cell Survival Genes in Neurogenesis and Neural Regeneration
$965,000.00
Nov 1, 2011
For-profit organization
509585
509585
Trillium Therapeutics is a biotechnology company specializing in innovative therapies of immunology and ctyoprotection. Funds will help commercialize a therapeutic treatment for interstitial cystitis.
$733,985.00
Oct 1, 2011
Investigation into the molecular mechanisms mediating excitotoxicity - developing novel post-stroke therapies
$339,058.00
Oct 1, 2011
Advancing gel dosimetry for clinical radiation therapy
$293,267.00
Oct 1, 2011
Bone marrow-derived stem cell-based gene therapy to accelerate fracture healing
$506,269.00
Oct 1, 2011
Pilot study of highly active anti-retroviral therapy for patients with primary biliary cirrhosis
$810,974.00
Oct 1, 2011
Chromatin modulation associated with gene regulation: Interplay between histone chaperones and epigenetic marks
$791,150.00
Oct 1, 2011
Strategies for gene discovery in schizophrenia: subphenotypes, deep sequencing, and interactions
$822,107.00
Oct 1, 2011
Evaluation of a new cognitive therapy (inference-based therapy) for the treatment of obsessional compulsive disorder